Back to search
Atypical Parkinsonism
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Atypical Parkinsonism trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Atypical Parkinsonism trials you may qualify forThe goal of this observational study is to learn about the impact of the different types of pain and of the domains involved in the autonomic disorders of inpat…
The Swedish BioFINDER 2 study is a new study that will launch in 2017 and extends the previous cohorts of BioFINDER 1 study (www.biofinder.se). BioFINDER 1 is u…
Clinical diagnosis of Parkinson's disease (PD), multiple system atrophy (MSA) and dementia with Lewy bodies (DLB) is challenging, especially in the early stages…
The PD-HemON study aims to evaluate the safety and preliminary efficacy of ARC-IM Therapy (Epidural Electrical Stimulation) to support hemodynamic management in…
This study aims to verify transcranial direct current stimulation(tDCS) efficacy for Parkinson's disease (PD)-related dysphagia and its mechanism. Subjects are…
Every-day life means being part of a complex environment and performing complex tasks that usually involve a combination of motor and cognitive skills. However,…
A35-009 (ORION) is a Phase 2b/3 trial to evaluate the efficacy and safety of AMX0035 in participants with Progressive Supranuclear Palsy (PSP), consisting of ra…
This project aims to investigate whether an integrated model based on proactive and reactive telenursing monitoring coordinated by a parkinsonism nurse speciali…
This study seeks to correlate microbiome sequencing data with information provided by patients and their medical records regarding Parkinson's Disease.